Pierre Heimendinger
Corporate Officer/Principal en TXCELL .
Perfil
Pierre Heimendinger is currently the Vice President-Process Development at Sangamo Therapeutics France SAS.
He holds a doctorate degree from Université Paris Diderot-Paris 7.
Cargos activos de Pierre Heimendinger
| Empresas | Cargo | Inicio |
|---|---|---|
| TXCELL | Corporate Officer/Principal | - |
Formación de Pierre Heimendinger.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
| Université Paris Diderot-Paris 7 | Consumer Services |
- Bolsa de valores
- Insiders
- Pierre Heimendinger
